Capacitive-Resistive Monopolar Radiofrequency Appears Safe, Effective for Genitourinary Syndrome of Menopause

Follow Drugslib on

By Lori Solomon HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on Feb 19, 2026.

via HealthDay

THURSDAY, Feb. 19, 2026 -- Capacitive-resistive monopolar radiofrequency significantly improved sexual function and vaginal health in women with genitourinary syndrome of menopause, according to a study published online Feb. 10 in Menopause.

Claudia Quezada-Bascuñán, P.T., from the University of Castilla-La Mancha in Toledo, Spain, and colleagues evaluated the efficacy of nonablative capacitive-resistive monopolar radiofrequency on sexual function and vaginal health in postmenopausal women. The analysis included women with genitourinary syndrome of menopause randomly assigned to six weekly sessions of capacitive-resistive monopolar radiofrequency (32 women) or sham treatment (30 women).

The researchers found that the intervention group showed significantly greater improvements in the Female Sexual Function Index (FSFI) at posttreatment and at the 12-week follow-up (mean changes, 5.86 versus 1.33 at posttreatment and 4.41 versus −0.41 at 12 weeks). Similar trends were seen for the Vaginal Health Index (VHI; mean changes, 4.75 versus −0.03 at posttreatment and 6.90 versus −0.66 at follow-up). For the FSFI, the effect sizes were moderate to large (Cohen's d >0.77), and the effect sizes were large for the VHI (d >3.49). There were no significant changes in estrogenic status. No adverse events were reported.

"This small study provides preliminary evidence on the effectiveness of nonablative radiofrequency on vaginal health and sexual function in postmenopausal women," Stephanie Faubion, M.D., medical director for The Menopause Society, said in a statement. "Additional studies in larger and more diverse cohorts with multidimensional outcome assessments and longer-term follow-up are needed to confirm clinical applicability."

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2026-02-20 09:26

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords